NCCN Guidelines for Patients® | Ovarian Cancer - page 97

97
NCCN Guidelines for Patients
®
: Ovarian cancer
Version 1.2013
Index
Recurrence treatment
3, 49, 50, 56, 58–68
Reproductive organs
6, 18, 76, 77
Ovary, ovaries
4, 6, 7, 9, 11, 13–16, 23–25, 29–32,
34, 35, 37–39, 46, 55, 56, 67, 77
Fallopian tube
6, 7, 14, 15, 25, 29, 31, 32, 35, 37–39,
55, 56, 67, 77
Uterus
6, 7, 13–15, 20, 25, 29, 31, 32, 35, 37–39, 55,
56, 67, 77
Side effect
15, 30, 44, 48–51, 62, 63, 71, 77–79
Staging
22–24, 27, 29, 31–39, 47, 65, 67
Surgery
3, 11, 12, 18, 22, 23, 27–39, 41–43, 46–48, 55,
56, 64–67, 76
Bilateral salpingo-oophorectomy (BSO)
29, 39
Completion surgery
34–38, 55, 56
Hysterectomy
29, 39
Laparotomy
29, 32, 33
Unilateral salpingo-oophorectomy (USO)
29, 39
Surgical staging, staging procedures
23, 27, 29, 31–35,
37, 38, 47, 67
Survivorship
78, 81
Symptoms
3, 11, 12, 16, 20, 30, 37, 49, 50, 63–65, 67,
68, 78, 79
Targeted therapy
41, 60–62, 76
Tests
3, 10–20, 22–24, 31, 33, 35, 37, 38, 43, 47–51,
54–57, 63–68, 76–81
Blood tests
12, 17, 18, 20, 43, 48, 49, 55–57, 63
Family medical history
12, 13, 56
Imaging tests
12, 14, 15, 48, 49, 55–57, 63–65, 67,
68, 80
Medical history
12, 13
Pelvic exam
12, 13, 20, 48, 55, 56
Tissue tests
22, 23
Treatment planning
3, 11, 21–27, 77, 78
Treatment response
48–50, 53, 77
Tumor markers
12, 18, 55
Ultrasound
14, 15, 55, 56
1...,87,88,89,90,91,92,93,94,95,96 98,99,100
Powered by FlippingBook